1 week Ago By ABMN Staff
Rosenblatt Securities restated their buy rating on shares of IMAX ( NYSE:IMAX – Free Report ) in a research report report published on Thursday morning, Benzinga reports. Rosenblatt Securities currently has a $35.00 price objective on the stock.
A number of other analysts also recently issued reports on IMAX. Macquarie raised their price target on shares of IMAX from $28.00 to $30.
00 and gave the stock an “outperform” rating in a report on Thursday, February 20th. Wells Fargo & Company lifted their target price on IMAX from $26.00 to $32.
00 and gave the company an “overweight” rating in a research report on Thursday, February 20th. Wedbush reiterated an “outperform” rating and set a $32.00 price target on shares of IMAX in a report on Thursday, February 20th.
JPMorgan Chase & Co. boosted their price objective on shares of IMAX from $25.00 to $27.
00 and gave the company a “neutral” rating in a report on Friday, February 21st. Finally, Benchmark reaffirmed a “buy” rating and set a $30.00 target price on shares of IMAX in a research note on Thursday.
Two research analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $30.56.
Read Our Latest Stock Analysis on IMAX IMAX Stock Performance IMAX ( NYSE:IMAX – Get Free Report ) last announced its quarterly earnings results on Wednesday, February 19th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.
31 by ($0.14). IMAX had a net margin of 7.
40% and a return on equity of 8.60%. The firm had revenue of $92.
67 million for the quarter, compared to analyst estimates of $104.08 million. On average, analysts predict that IMAX will post 0.
91 EPS for the current fiscal year. Institutional Inflows and Outflows A number of institutional investors have recently made changes to their positions in the business. Blue Trust Inc.
boosted its position in IMAX by 138.5% in the 4th quarter. Blue Trust Inc.
now owns 966 shares of the company’s stock valued at $25,000 after buying an additional 561 shares during the period. Tower Research Capital LLC TRC boosted its holdings in IMAX by 415.4% in the fourth quarter.
Tower Research Capital LLC TRC now owns 7,236 shares of the company’s stock valued at $185,000 after purchasing an additional 5,832 shares during the period. Wealthfront Advisers LLC acquired a new position in IMAX during the 4th quarter worth $217,000. Cornerstone Investment Partners LLC purchased a new position in shares of IMAX in the 4th quarter valued at about $248,000.
Finally, Savant Capital LLC acquired a new position in shares of IMAX during the fourth quarter worth about $249,000. Institutional investors and hedge funds own 93.51% of the company’s stock.
About IMAX ( Get Free Report ) IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
Featured Articles Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter ..
